Tanaka Y, Miyama T, Suda Y, Fujita K, Takubo K
Dept. of Pathology, Saitama Cancer Center.
Gan To Kagaku Ryoho. 1991 Aug;18(11):1780-3.
We studied the effects of OK-432 administered preoperatively on the cellular immunity and prognosis of patients with esophageal cancer. The preoperative injection of OK-432 was effective to preserve the NK activity in the peripheral blood. Especially the local priming and eliciting with OK-432 seemed to contribute to the activation of NK cells in the regional lymph nodes and to the improved prognosis of the patients.
我们研究了术前给予沙培林(OK-432)对食管癌患者细胞免疫及预后的影响。术前注射沙培林(OK-432)可有效维持外周血中的自然杀伤细胞(NK)活性。尤其是局部给予沙培林(OK-432)进行激发,似乎有助于激活区域淋巴结中的NK细胞,并改善患者的预后。